Document Detail

The metabolic syndrome and cardiovascular risk in Cushing's syndrome.
MedLine Citation:
PMID:  15850845     Owner:  NLM     Status:  MEDLINE    
Cushing's syndrome (CS) is characterized by a series of systemic complications that increase cardiovascular risk and cause severe atherosclerotic damage that develops in parallel with an acquired metabolic syndrome. Short-term remission from hypercortisolism improves metabolic and vascular damages, but long-term remission from CS seems to be associated with similar or worse metabolic and vascular damage, probably because of persistent abdominal obesity or insulin resistance years after normalization of cortisol secretion. Study results suggest that an increased cardiovascular risk also may persist in patients who undergo treatment with exogenous glucocorticoids after therapy withdrawal. Considering the many patients subjected to corticosteroid treatment, this could be of great clinical relevance and should be investigated thoroughly.
Rosario Pivonello; Antongiulio Faggiano; Gaetano Lombardi; Annamaria Colao
Related Documents :
20844915 - Effects of renal dysfunction on cardiovascular events in diabetic patients with hyperte...
20604675 - Clinical and subclinical atherosclerosis in systemic sclerosis: consequences of previou...
16156505 - An angiotensin receptor blocker reduces the risk of congestive heart failure in elderly...
17547715 - Validation of a clinical prognostic model to identify low-risk patients with pulmonary ...
22213835 - Dural arteriovenous fistulae in pediatric patients: associated conditions and treatment...
23423465 - A cohort study on myasthenia gravis patients in china.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Endocrinology and metabolism clinics of North America     Volume:  34     ISSN:  0889-8529     ISO Abbreviation:  Endocrinol. Metab. Clin. North Am.     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-04-26     Completed Date:  2005-06-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8800104     Medline TA:  Endocrinol Metab Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  327-39, viii     Citation Subset:  IM    
Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Via Sergio Pansini 5, Naples 80131, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiovascular Diseases / epidemiology*,  physiopathology
Metabolic Syndrome X / epidemiology*,  physiopathology
Pituitary ACTH Hypersecretion / epidemiology*,  physiopathology
Risk Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Glucocorticoid resistance and hypersensitivity.
Next Document:  Osteoporosis associated with excess glucocorticoids.